Acadia Pharmaceuticals (NASD: ACAD) will be added to the S&P SmallCap 600 prior to the opening of trading on Jan 3, 2025, replacing Independent Bank Group (NASD: IBTX).
The change follows an announced acquisition involving SouthState (NYSE: SSB) and is effective before the market open on the stated date. For details, see S&P Dow Jones Indices.
Loading...
Loading translation...
Positive
None.
Negative
None.
Market Context
This announcement highlights that IBTX is scheduled to be deleted from a major index on Jan 3, 2025 ...
Analysis
This announcement highlights that IBTX is scheduled to be deleted from a major index on Jan 3, 2025 due to its pending acquisition, while trading volume of 1,537,999 shares already sits well above its recent average. Index changes often prompt activity from passive and quantitative strategies. With no detailed historical or regulatory context provided here, key items to monitor include deal-closing progress, any updates to transaction conditions, and how index removal affects liquidity and ownership structure.
Key Figures
Effective date:Jan 3, 2025
1 metrics
Effective dateJan 3, 2025Date IBTX is deleted from S&P SmallCap 600
A stock market index made up of 600 small-cap U.S. companies chosen to represent the performance of smaller publicly traded firms. It matters to investors because it acts like a temperature gauge for the small-company segment of the market, serving as a benchmark for fund managers, a basis for index funds and ETFs, and a way to compare returns and risk when building a diversified portfolio.
s&p midcap 400financial
"S&P MidCap 400 constituent SouthState Corp. (NYSE: SSB) is acquiring..."
The S&P MidCap 400 is a group of 400 companies that are smaller than the big, well-known corporations but larger than tiny startups. It helps investors see how medium-sized companies are performing in the stock market, acting like a barometer for this middle-sized group of businesses.
gics sectortechnical
"Effective Date | Index Name | Action | Company Name | Ticker | GICS Sector"
GICS sector is one of the major industry groupings from the Global Industry Classification Standard, a system that sorts companies into consistent categories (like Technology or Health Care) based on the primary business they do. Investors use these sectors like folders in a filing cabinet to compare companies, build diversified portfolios, and track how whole parts of the market are performing rather than focusing on single stocks.
NEW YORK, Dec. 30, 2024 /PRNewswire/ -- Acadia Pharmaceuticals Inc. (NASD: ACAD) will replace Independent Bank Group Inc. (NASD: IBTX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 3, 2025. S&P MidCap 400 constituent SouthState Corp. (NYSE: SSB) is acquiring Independent Bank Group in a deal expected to close soon pending final conditions.
Following is a summary of the change that will take place prior to the open of trading on the effective date:
Effective Date
Index Name
Action
Company Name
Ticker
GICS Sector
Jan 3, 2025
S&P SmallCap 600
Addition
Acadia Pharmaceuticals
ACAD
Health Care
Jan 3, 2025
S&P SmallCap 600
Deletion
Independent Bank Group
IBTX
Financials
For more information about S&P Dow Jones Indices, please visit www.spdji.com
ABOUT S&P DOW JONES INDICES
S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.
S&P Dow Jones Indices is a division of S&P Global (NYSE: SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com.
What does Acadia Pharmaceuticals (ACAD) joining the S&P SmallCap 600 mean for shareholders on Jan 3, 2025?
ACAD's addition means inclusion in the S&P SmallCap 600 index starting Jan 3, 2025, potentially raising index-tracker demand. According to S&P Dow Jones Indices, ACAD replaces Independent Bank Group (IBTX) effective prior to the open on that date.
Why is Independent Bank Group (IBTX) being removed from the S&P SmallCap 600 on Jan 3, 2025?
IBTX is being deleted because it is being acquired by SouthState (SSB), prompting index reconstitution. According to S&P Dow Jones Indices, IBTX will be removed prior to the market open on Jan 3, 2025.
Will the S&P SmallCap 600 change for Acadia (ACAD) affect trading at the market open on Jan 3, 2025?
The index change is effective prior to the opening on Jan 3, 2025, so inclusion will be reflected at the market open. According to S&P Dow Jones Indices, ACAD will be added and IBTX deleted before trading begins.
How should investors confirm the S&P SmallCap 600 reconstitution involving Acadia (ACAD) on Jan 3, 2025?
Investors should verify index changes via S&P Dow Jones Indices and official market notices ahead of Jan 3, 2025. According to S&P Dow Jones Indices, ACAD is scheduled for addition and IBTX for deletion prior to the open.
Does the press release mention the role of SouthState (SSB) in the index change involving Independent Bank Group (IBTX)?
Yes. The release notes SouthState (SSB) is acquiring Independent Bank Group, which is the reason for IBTX's removal. According to S&P Dow Jones Indices, the acquisition is expected to close soon pending final conditions.
View original content:https://www.prnewswire.com/news-releases/acadia-pharmaceuticals-set-to-join-sp-smallcap-600-302340435.html